asciminib 20 MG Oral Tablet
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
asciminib 20 MG Oral Tablet
20 MG · Oral Tablet · oral
A form of asciminib →
asciminib 20 MG Oral Tablet — BCR-ABL tyrosine kinase inhibitors. Strength, form, class, interactions & more.
Active ingredient
Classification
BCR-ABL tyrosine kinase inhibitors
Drug interactions
Asciminib has several interactions with CYP3A4, CYP2C9, P-gp, and BCRP substrates, which may increase the risk of adverse reactions.
- majorstrong CYP3A4 inhibitors — increased risk of adverse reactions
- majoritraconazole oral solution containing hydroxypropyl-β-cyclodextrin — reduced efficacy of SCEMBLIX
- moderatestrong CYP3A4 inducers — decreased plasma concentrations of asciminib
- majorcertain CYP3A4 substrates — increased risk of adverse reactions
- majorCYP2C9 substrates — increased risk of adverse reactions
- moderatecertain P-gp substrates — increased risk of adverse reactions
- majorrosuvastatin — increased risk of adverse reactions
Real-world adverse events (FAERS)
Fatigue236Death170Nausea170Drug Ineffective162Thrombocytopenia146Headache123Diarrhoea122Drug Intolerance121
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication